BRAF-targeted therapy alters the functions of intratumoral CD4<sup>+</sup> T cells to inhibit melanoma progression.

Details

Serval ID
serval:BIB_7C3678EE2D42
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Title
BRAF-targeted therapy alters the functions of intratumoral CD4<sup>+</sup> T cells to inhibit melanoma progression.
Journal
Oncoimmunology
Author(s)
Ho P.C., Kaech S.M.
ISSN
2162-4011 (Print)
ISSN-L
2162-4011
Publication state
Published
Issued date
18/06/2014
Peer-reviewed
Oui
Volume
3
Pages
e29126
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
Abstract
The establishment of an immunosuppressive tumor microenvironment is a hallmark feature driving cancer cell evasion of immunosurveillance. In a murine melanoma model, we recently demonstrated that decreased intratumoral CD4 <sup>+</sup> T-cell expression of CD40L and interferon γ (IFNγ) is critical to maintain this immunosuppressive microenvironment. Altered effector functions of tumor-associated CD4 <sup>+</sup> T cells is essential for B-Raf <sup>V600E</sup> inhibitor-mediated restoration of antitumor immunity.
Keywords
BRAF, CD40L, IFNγ, T cell, melanoma
Pubmed
Web of science
Open Access
Yes
Create date
05/04/2019 15:50
Last modification date
20/08/2019 14:37
Usage data